Biomea Fusion - Rasio total nilai perusahaan marang pendapatan BMEA

Logo perusahaan publik biomeafusion.com (BMEA)

The EV/Sales valuation chart demonstrates market expectations for Biomea Fusion, Inc. (BMEA), where the 0.00 metric indicates the business value status. This price action is driven by the utilization of the FUSION system to combat metabolic dysfunction. Risks are mitigated by the development of covalent drugs targeting oncology and diabetes. Efficiency is maintained through external testing while retaining intellectual property rights.

BMEA Biomea Fusion, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Biomea Fusion Corp - rincian analitis lan metrik utama (BMEA)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:BMEA, biomeafusion.com
Barang unggulan Biomea

This metric determines the market value of the business, excluding the impact of debt load on total capitalization. An analysis of the enterprise value-to-revenue ratio allows for tracking the efficiency of sales generation relative to the asset price. The metric compares the total enterprise value with the volume of services rendered. For Biomea Fusion, Inc. (BMEA), this is critical, as lifelong therapy for metabolic disorders ensures a stable revenue stream. The high margins of such products make this indicator key to assessing the fundamental stability of the company.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)